Study

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. – Cost Effective Supplements

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/22085343


Conclusion of this study

Among patients with atherosclerotic cardiovascular disease and LDL cholesterol levels of less than 70 mg per deciliter (1.81 mmol per liter), there was no incremental clinical benefit from the addition of niacin to statin therapy during a 36-month follow-up period, despite significant improvements in HDL cholesterol and triglyceride levels. (Funded by the National Heart, Lung, and Blood Institute and Abbott Laboratories; AIM-HIGH ClinicalTrials.gov number, NCT00120289.).


Supplements analyzed in this study

Vitamin B3

Health conditions analyzed in this study

Heart Attack


Slightly Positive
Vitamin B3

Stroke


Slightly Positive
Vitamin B3


Functions related to this study

Heart health


Highly Positive
Vitamin B3

Mental health


Slightly Positive
Vitamin B3


Body systems related to this study


Cardiovascular System

Nervous System
Scroll to top